Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement
Search
Recent Posts
- Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research
- Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England’s 100,000 Genomes Project to Advance Rare Disease Research
- The Metabolon Verus™ Metabolomics Profiling Kit: The easiest way to put metabolomics into your multiomics
- The Metabolites Complete the Story: Metabolomics is Essential for Truly Translational Science
- The Connective Science: How metabolomics and interdisciplinary collaboration are reshaping translational science
Recent Comments